Eli Lilly Issues Warning About Fake Weight-Loss Drugs

On June 20, Eli Lilly published an open letter, warning about fake and compounded versions of Mounjaro and Zepbound, ABC News reports. "Lilly is committed to making life better for people living with diabetes and obesity through developing medicines that change the way healthcare providers can treat these diseases.", Eli Lilly, via open letter.